Get in the Ideas Business.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible.
As we work together to discover, invent, and develop biopharmaceutical medicines, we’re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health.
So connect with us. Tell us about you. Learn more about our life-changing medicines. And join us, as we build a future we believe in.
Closing share price
|FY, 2013||FY, 2014||FY, 2015||FY, 2016|
|$2.1 b||$2.8 b||$4.1 b||$4.9 b|
Revenue growth, %
|$2 b||$2.7 b||$3.9 b|
Operating expense total
|$1.2 b||$1.9 b||$2.6 b|
|$760 m||$838.4 m||$1.3 b|
|$424.4 m||$348.1 m||$636.1 m||$895.5 m|
Operating cash flow
|$305.3 m||$113.1 m||$160.4 m|